Premium
Juvenile myoclonic epilepsy phenotype in a family with Unverricht‐Lundborg disease
Author(s) -
Berrechid Amina Gargouri,
Bendjebara Mouna,
Bouteiller Delphine,
Nasri Amina,
Peuvion JeanNoël,
Marie Yannick,
Baulac Stéphanie,
Mrabet Saloua,
Ribierre Théo,
Cazeneuve Cecile,
Leguern Eric,
Gouider Riadh
Publication year - 2019
Publication title -
epileptic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.673
H-Index - 53
eISSN - 1950-6945
pISSN - 1294-9361
DOI - 10.1684/epd.2019.1078
Subject(s) - juvenile myoclonic epilepsy , progressive myoclonus epilepsy , medicine , epilepsy , myoclonus , myoclonic epilepsy , psychiatry
ABSTRACT Aims . Unverricht‐Lundborg disease (ULD), an autosomal recessive progressive myoclonus epilepsy, is due to an expansion, or less commonly a mutation, of the cystatin B ( CSTB ) gene. We report a clinical and molecular study of a Tunisian ULD family with five affected members presenting with a juvenile myoclonic epilepsy (JME)‐like phenotype. Methods . The expansion of dodecamers was detected by a deamination/PCR assay. The expression profiles of CSTB and other candidate modifying genes, cathepsin B and cystatin C, were established by quantitative RT‐PCR, and their respective transcription levels were compared with those from patients with a classic picture of ULD. Results . Three patients had a fixed phenotype mimicking JME after 29 years of evolution. Only a discrete dysarthria was noticed in the two other patients. No correlation was observed between transcription level and severity of disease. Conclusion . Genetic screening should be performed in patients with a JME‐like phenotype, when careful examination reveals discrete atypical signs of JME. This particular phenotype may be due to modifying genes and/or gene‐environment interactions which require further clarification.